Advancing formulation to improve lives
From IV to a quick shot
Imagine the difference in quality of life for the patient whose previous 8-hour IV treatment in a hospital could now be administered via a single subcutaneous injection at home.
The EXCELSE™ formulation technology represents that breakthrough in lifecycle management, patient care and the delivery of biotechnology drugs.
25% of biologic drugs require a lengthy IV administration, while 50% require use of a lyophilized formulation to stabilize. Both these solutions are highly inconvenient to patients, and costly for payers. Now, these same therapies can be administered via a single, simple injection when formulated with EXCELSE™ technology.
Volume and times savings of 10X or more have been achieved in the delivery of biotechnology medicines formulated with EXCELSE™.
For patients managing chronic illnesses such as diabetes, oncology, primary immune deficiency, hemophilia, the potential for improved patient experience is tremendous.